• Home Page

• About

  • Overview of Biopad
  • Organizational Structure
  • Board of Trustees
  • FAQ

• Portfolio

  • Focus Areas
    • Animal Health
    • Human Health
    • Industrial
    • SA Malaria Initiative
  • How to Apply
  • Investment

• Industry Development

  • Knowledge Management
  • Human Capacity Development
  • Marketing

• Events

  • Events Calender

• Publications

  • Annual Reports
  • Newsletters
  • Industry Publications
  • Academic Publications

• Contact

Animal Health

By improving the health and well being of animals, we also protect and improve human health and well-being. Animal diseases cost worldwide agriculture $17 billion each year, according to the Congress Office of Technology Assessment. To help prevent these losses, animal scientists are using biotechnology to develop an array of products to diagnose, treat, and prevent disease in animals.

Main Objectives of Animal Health portfolio

• Identify and develop projects leading to the development of novel diagnostic tests, drugs and other products for diseases carried out by research teams of collaborating investigators and institutions in our region.
• Provide a platform and framework for scientific, legal and ethical support to facilitate the commercialization of research outcomes in biotechnology in selected focus areas.
• Facilitate creation of 'spin-offs' (e.g. public private partnerships, networks of academic institutions and not-for profit foundations) focusing on and dedicated to innovation for discovery and development of drugs and diagnostic tests in South Africa.

Current Activities for 2009/10
Novel Delivery Systems for animal vaccines
Veterinary diseases such as foot and mouth disease (FMD), blue tongue (BT), African horse sickness (AHS) and highly pathogenic avian influenza (HPAI) has a worldwide social and economic impact.  These diseases are usually controlled by either inactivated or live-attenuated viral vaccines and there is a well established market for them.             
The platform is a continuation of a BioPAD funded project and results from that project indicated that antigens can be successfully displayed on the surface of soluble trimers of AHSV capsid protein VP7 or on the surface of tubular particles composed of AHSV non structural protein NS1. Further development is currently in progress. See Link to animal heath projects
Embryo Transfer

Portfolio Manager
Bonginkosi Gumede, PhD
Portfolio Manager: Animal Health
Tel: +27 (0) 12 844 0145
Fax: +27 (0) 12 844 0153
E-mail: bonginkosi@biopad.org.za